Senin, 08 Juni 2026 - 20:05 WIB

Find and Follow Us

Global Markets

IHSG 5,342.14 -4.52%

S&P 500 7,383.74 -2.64%

NASDAQ 25,709.43 -4.18%

Dow Jones 50,866.78 -1.35%

FTSE 100 10,374.42 +0.06%

CAC 40 8,192.23 -0.32%

Nikkei 225 64,024.60 -3.85%

Hang Seng 24,657.06 -1.22%

Shanghai 3,959.34 -1.70%

KOSPI 7,484.41 -8.29%

STI 4,963.67 -1.71%

ASX 200 8,625.10 -0.70%

Sensex 73,524.26 -0.97%

Gold 4,355.30 +0.42%

Silver 68.90 -0.06%

Oil (WTI) 91.68 +1.26%

Brent 94.61 +1.63%

Copper 6.38 +1.88%

Gas Alam 3.14 -2.66%

Bitcoin 63,690.97 +0.71%

Ethereum 1,690.42 +0.24%

USD/IDR 18,166.00 +1.17%

EUR/USD 1.15 -0.55%

Advertisement

Vidjongtius Direktur Utama PT Kalbe Farma Tbk (Foto Swa.com)

Kalbe Farma Bangun Pabrik Biosimilar Bernilai Rp700 Miliar

Redaksi • 27 Februari 2018

Latest Updates

- Advertisement -

Vidjongtius Direktur Utama PT Kalbe Farma Tbk (Foto Swa.com)

10:05 WIB • 27 Februari 2018

Kalbe Farma Bangun Pabrik Biosimilar Bernilai Rp700 Miliar

PT Kalbe Farma Tbk (KLBF) mendirikan pabrik biosimilar, yaitu pabrik bahan baku obat dan produk biologi, di Kawasan Industri…